AI Analysis AI Analysis of ABBV AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ABBV to Watchlist?
Some Reasons Why To Add ABBV:
  • Excellent financial health (Piotroski 7/9)
  • Beat earnings estimates in 3 of the last 4 quarters
  • Strong return on equity of 68.0%
PDF

AbbVie stock upgraded from Sell Candidate to Buy Candidate after Wednesday trading session
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Jun 03, 2026

The AbbVie stock price gained 0.761% on the last trading day (Wednesday, 3rd Jun 2026), rising from $215.43 to $217.07. During the last trading day the stock fluctuated 2.72% from a day low at $213.73 to a day high of $219.54. The price has risen in 6 of the last 10 days and is up by 1.5% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 360 thousand more shares were traded than the day before. In total, 6 million shares were bought and sold for approximately $1.21 billion.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $217.99 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -4.60% during the next 3 months and, with a 90% probability hold a price between $184.17 and $207.97 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ABBV Signals & Forecast

The AbbVie stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $215.75 and $208.34. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -0.727%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for AbbVie stock

AbbVie finds support from accumulated volume at $211.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $5.82 (2.72%) between high and low. For the last week, the stock has had daily average volatility of 2.50%.

Our recommended stop-loss: $208.49 (-3.95%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (ABBV) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect AbbVie Inc to open at $216.78, and during the day (based on 14 day Average True Range), to move between $214.37 and $219.77, which gives a possible trading interval of +/-$5.40 (+/-2.52%) up or down from last closing price. If AbbVie Inc takes out the full calculated possible swing range there will be an estimated 2.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $211.33 (2.64%) than the resistance at $227.45 (4.78%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is AbbVie Inc stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 1.016 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $216.78 ( 0.134%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ABBV Performance

Trading levels for ABBV

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 222.59 2.54%
R2 220.37 1.52%
R1 219.00 0.89%
Price 217.07
S1 214.56 -1.16%
S2 213.18 -1.79%
S3 210.96 -2.81%

Accumulated Volume Support & Resistance Levels

Level Price
R3 232.35 7.04%
R2 230.11 6.01%
R1 227.45 4.78%
Price 217.07
S1 211.33 -2.64%
S2 205.07 -5.53%
S3 204.35 -5.86%

ABBV Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 19, 2026 Apr 15, 2026 May 15, 2026 $1.73 0.754%
2 Oct 31, 2025 Jan 16, 2026 Feb 17, 2026 $1.73 0.82%
3 Sep 05, 2025 Oct 15, 2025 Nov 14, 2025 $1.64 0.782%
4 Jun 20, 2025 Jul 15, 2025 Aug 15, 2025 $1.64 0.88%
5 Apr 15, 2025 Apr 15, 2025 May 15, 2025 $1.64 0.90%

FAQ

What is the symbol for AbbVie Stock and on which exchange is it traded?
The symbol for AbbVie is ABBV and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell AbbVie Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy AbbVie Stock?
AbbVie Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AbbVie Stock.

What's the current price of AbbVie Stock?
As of the end of day on the Jun 03, 2026, the price of an AbbVie (ABBV) share was $217.07.

What is the 52-week high and low for AbbVie Stock?
The 52-week high for AbbVie Stock is $244.81 and the 52-week low is $181.80.

What is the market capitalization of AbbVie Stock?
As of the Jun 03, 2026, the market capitalization of AbbVie is 383.518B.

When is the next earnings date for AbbVie?
The upcoming earnings date for AbbVie is Jul 30, 2026.
Click to get the best stock tips daily for free!
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE